Ahmet F. Oruc
Konya, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 31, 2026
Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss.
Journal: Laryngoscope investigative otolaryngology
Published: April 25, 2026
Assessing Early Treatment Response in mCSPC Using KELIM PSA Score: Implications for Survival.
Journal: Urologia internationalis
Published: March 26, 2026
The effect of tolvaptan on total kidney volume and inflammatory markers in autosomal dominant polycystic kidney disease.
Journal: Clinical and experimental nephrology
Published: March 25, 2026
Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancer.
Journal: Experimental hematology & oncology
Published: February 19, 2026
Orthostatic hypotension as a marker of increased arterial stiffness in diabetes mellitus.
Journal: Acta diabetologica
Published: February 13, 2026
Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: January 24, 2026
Antibody-drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure.
Journal: Breast (Edinburgh, Scotland)
Published: January 21, 2026
The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective study.
Journal: Scientific reports
Published: January 07, 2026
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study.
Journal: Journal of chemotherapy (Florence, Italy)
Published: December 19, 2025
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study.
Journal: Therapeutic advances in medical oncology
Published: December 19, 2025
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 14, 2025
Last Updated: 09/26/2026